Osaic Holdings’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Sell |
1,190,535
-32,881
| -3% | -$42.6K | ﹤0.01% | 1880 |
|
|
2025
Q1 | $1.49M | Buy |
1,223,416
+42,881
| +4% | +$52.3K | ﹤0.01% | 1898 |
|
|
2024
Q4 | $1.52M | Sell |
1,180,535
-1,560
| -0.1% | -$2.01K | ﹤0.01% | 1872 |
|
|
2024
Q3 | $3.25M | Buy |
1,182,095
+56,100
| +5% | +$154K | 0.01% | 1346 |
|
|
2024
Q2 | $2.54M | Sell |
1,125,995
-138,850
| -11% | -$314K | 0.01% | 1448 |
|
|
2024
Q1 | $3.02M | Buy |
1,264,845
+13,797
| +1% | +$33K | 0.01% | 1392 |
|
|
2023
Q4 | $2.08M | Sell |
1,251,048
-2,024,144
| -62% | -$3.36M | ﹤0.01% | 1830 |
|
|
2023
Q3 | $6.29M | Buy |
3,275,192
+1,839,635
| +128% | +$3.53M | 0.01% | 1161 |
|
|
2023
Q2 | $2.07M | Buy |
1,435,557
+163,797
| +13% | +$236K | ﹤0.01% | 1840 |
|
|
2023
Q1 | $2.67M | Buy |
1,271,760
+1,432
| +0.1% | +$3.01K | 0.01% | 1600 |
|
|
2022
Q4 | $1.44M | Sell |
1,270,328
-31,794
| -2% | -$35.9K | ﹤0.01% | 2022 |
|
|
2022
Q3 | $2.12M | Buy |
1,302,122
+17,641
| +1% | +$28.8K | ﹤0.01% | 1591 |
|
|
2022
Q2 | $1.68M | Buy |
1,284,481
+18,661
| +1% | +$24.5K | ﹤0.01% | 1793 |
|
|
2022
Q1 | $2.04M | Buy |
1,265,820
+18,419
| +1% | +$29.7K | ﹤0.01% | 1904 |
|
|
2021
Q4 | $2.58M | Sell |
1,247,401
-26,556
| -2% | -$55K | ﹤0.01% | 1556 |
|
|
2021
Q3 | $4.94M | Buy |
1,273,957
+800
| +0.1% | +$3.1K | 0.01% | 1066 |
|
|
2021
Q2 | $4.07M | Buy |
1,273,157
+51,173
| +4% | +$164K | 0.01% | 1165 |
|
|
2021
Q1 | $2.65M | Buy |
1,221,984
+126,009
| +11% | +$273K | 0.01% | 1386 |
|
|
2020
Q4 | $2.45M | Buy |
1,095,975
+60,154
| +6% | +$135K | 0.01% | 1290 |
|
|
2020
Q3 | $2.77M | Buy |
1,035,821
+23,391
| +2% | +$62.4K | 0.01% | 1112 |
|
|
2020
Q2 | $3.1M | Buy |
1,012,430
+148,155
| +17% | +$453K | 0.01% | 972 |
|
|
2020
Q1 | $1.69M | Buy |
+864,275
| New | +$1.69M | 0.01% | 1168 |
|